Biotech Updates

NTU Singapore Sheds Light on Link of COVID-19 and Blood Clot Formation

April 14, 2021

Individuals who have recovered from COVID-19, particularly those who have pre-existing heart ailments, are at risk of developing blood clots because of lingering and overactive immune responses. This is the result of the study conducted by Nanyang Technological University published in eLife.

The research team investigated the potential connection of COVID-19 and blood clot formation and provided more insights on "long haul COVID", which refers to medium- and long-term health effects of COVID-19. They collected blood samples from 30 COVID-19 patients 30 days after they have been discharged from the hospital. Their analyses showed that all patients had signs of blood vessel damage, potentially due to a lingering immune response, which may cause blood clotting.

"With more people recovering from COVID-19, we started hearing from clinicians about patients returning with blood clotting issues after they had been discharged and cleared of the virus," said NTU scientist Christine Cheung. "This makes a strong case for the close monitoring of recovered COVID-19 patients, especially those with pre-existing cardiovascular conditions like hypertension and diabetes who have weakened blood vessels."

Read more from NTU Singapore.

You might also like: